Clinical Trials Directory

Trials / Conditions / Acinetobacter Infections

Acinetobacter Infections

10 registered clinical trials studyying Acinetobacter Infections.

StatusTrialSponsorPhase
UnknownEfficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infect
NCT05586815
Mahidol UniversityPhase 4
UnknownClinical Outcomes in Patients With Infection by Resistant Microorganism
NCT05880069
Hospital Universitario Virgen Macarena—
TerminatedSeven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
NCT05210387
Hospital Moinhos de VentoN/A
CompletedColistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii
NCT03622918
Gangnam Severance HospitalN/A
CompletedImpact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961
DongGuk University—
CompletedPharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections
NCT02688322
Sutep JaruratanasirikulPhase 4
CompletedImpact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Col
NCT02573064
Maimónides Biomedical Research Institute of Córdoba—
CompletedMultinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Pro
NCT00524290
University of Pittsburgh—
CompletedClinical Outcomes and Global Epidemiology -Data Coordinating Center
NCT00524563
University of Pittsburgh—
CompletedRisk Factors for Carbapenem-resistant Acinetobacter Baumannii
NCT00462579
University of Pittsburgh—